Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses’ Health Study

Effects of lifestyle and single nucleotide polymorphisms on breast cancer risk: a case–control study in Japanese women

(2013) Taeko Mizoo et al.   BMC CANCER

Global Changes in the Mammary Epigenome Are Induced by Hormonal Cues and Coordinated by Ezh2

(2013) Bhupinder Pal et al.   Cell Reports

Global Levels of H3K27me3 Track with Differentiation in Vivo and Are Deregulated by MYC in Prostate Cancer

(2012) Laxmi G. Pellakuru et al.   AMERICAN JOURNAL OF PATHOLOGY

Reproductive and hormonal risk factors for luminal, HER2-overexpressing, and triple-negative breast cancer in Japanese women

(2012) T. Islam et al.   ANNALS OF ONCOLOGY

Magnesium intake, plasma C-peptide and colorectal cancer incidence in US women: a 28-year follow-up study

(2012) X Zhang et al.   BRITISH JOURNAL OF CANCER

A DNA hypermethylation module for the stem/progenitor cell signature of cancer

(2012) H. Easwaran et al.   GENOME RESEARCH

Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes

(2012) Karolina Holm et al.   Molecular Oncology

Sequence analysis of mutations and translocations across breast cancer subtypes

(2012) Shantanu Banerji et al.   NATURE

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Breast cancer risk–associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression

(2012) Richard Cowper-Sal·lari et al.   NATURE GENETICS

EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent

(2012) K. Xu et al.   SCIENCE

Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma

(2011) Sebastian Rogenhofer et al.   BJU INTERNATIONAL

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression

(2011) Sharon Hensley Alford et al.   BREAST CANCER RESEARCH AND TREATMENT

Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer

(2011) Rulla M. Tamimi et al.   BREAST CANCER RESEARCH AND TREATMENT

Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome

(2011) Yun Gong et al.   CANCER

Heterogeneity in breast cancer

(2011) Kornelia Polyak   JOURNAL OF CLINICAL INVESTIGATION

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

(2011) Laura C Collins et al.   MODERN PATHOLOGY

The Polycomb complex PRC2 and its mark in life

(2011) Raphaël Margueron et al.   NATURE

Viewing the Epigenetics of Colorectal Cancer through the Window of Folic Acid Effects

(2010) M. van Engeland et al.   Cancer Prevention Research

Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

(2010) Xiaohong R. Yang et al.   JNCI-Journal of the National Cancer Institute

Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples

(2010) M. Fanelli et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

FGFR2intronic polymorphisms interact with reproductive risk factors of breast cancer: Results of a case control study in Japan

(2009) Takakazu Kawase et al.   INTERNATIONAL JOURNAL OF CANCER

Reproductive and hormonal risk factors for postmenopausal luminal, HER-2-overexpressing, and triple-negative breast cancer

(2008) Amanda I. Phipps et al.   CANCER

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

(2008) Montserrat Garcia-Closas et al.   PLoS Genetics